NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,422 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
39,422 Papers indexed
1,440 Papers AI scored
39,422 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-10-18 09:15 AM
1 Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer. ESMO open — Oct 18, 2026 2 Cancer Treatment During Pregnancy and Maternal and Infant Outcomes: A Descriptive Cohort Study Using a Japanese Claims Database. Pharmacoepidemiology and drug safety — Oct 18, 2026 3 Multimodal modeling of the ictal onset zone in refractory insular epilepsy and seizure outcome of magnetic resonance-guided laser interstitial therapy: A pediatric single-center retrospective study. Epilepsia — Oct 18, 2026 4 Epstein-Barr Virus Association and Prognosis in Taiwanese Hodgkin Lymphoma: A Nationwide Multicenter Study With Comparison to United States Whites. International journal of cancer — Oct 18, 2026 5 Burden of CNS neoplasms in the Middle East and North Africa from 1990 to 2023, with projections to 2050: Insights from Global Burden of Disease. Medicine — Oct 18, 2026 6 Pediatric sellar and parasellar lesions: a population-based cohort study of presentation, management, and endocrine outcomes. Pituitary — Oct 18, 2026 7 Effects of structured music therapy on anxiety and mood in pediatric oncology patients. Journal of pediatric nursing — Oct 18, 2026 8 "My mom chose my brother over me": The influence of the parent-child bond on coping with a sibling's cancer. Journal of pediatric nursing — Oct 18, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39422 results
B
Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis.
PMID 40609017 Published: 2025-09-01 Ingested: 2026-08-02 12:05 AM The British journal of radiology
AI -
Standard 75.04
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 67.7; sample size: 80.0; recency: 100.0; abstract quality: 100.0.

B
Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
PMID 40084372 Published: 2025-02-15 Ingested: 2026-08-02 12:03 AM American journal of cancer research
AI -
Standard 75.04
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 50.2; sample size: 70.0; recency: 90.0; abstract quality: 100.0.

B
Quality of life and late therapy effects in pediatric non-Hodgkin lymphoma survivors: Insights from a single-institution study.
PMID 39370562 Published: 2024-10-06 Ingested: 2026-08-02 12:02 AM Pediatric blood & cancer
AI -
Standard 75.04
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 50.2; sample size: 70.0; recency: 90.0; abstract quality: 100.0.

B
Management of adverse events in patients with pediatric low-grade glioma treated with MAPK-directed therapies: Delphi consensus recommendations and unmet needs.
PMID 42131759 Published: 2026-02-06 Ingested: 2026-08-02 12:06 AM Neuro-oncology practice
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 75.0; human relevance: 90.0; therapeutic relevance: 50.1; sample size: 60.0; recency: 100.0; abstract quality: 85.0.

B
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study.
PMID 42080317 Published: 2026-05-04 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 60.1; sample size: 40.0; recency: 100.0; abstract quality: 100.0.

B
Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT Study.
PMID 42003563 Published: 2026-04-20 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 70.1; sample size: 90.0; recency: 100.0; abstract quality: 85.0.

B
Alveolar Soft Part Sarcoma: Clinicopathologic Analysis, Predictive Nomogram, and the Role of Adjuvant Radiation for Survival in a Retrospective Population-based Study.
PMID 40938110 Published: 2025-09-12 Ingested: 2026-08-02 12:05 AM American journal of clinical oncology
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 30.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

B
Improving outcomes in paediatric high-grade osteosarcoma: Insights from a retrospective survival study.
PMID 40894293 Published: 2025-08-14 Ingested: 2026-08-02 12:04 AM Journal of clinical orthopaedics and trauma
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 70.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

B
Adolescent Survivors of Childhood Cancer: Biopsychosocial Challenges and the Transition from Survival to Quality of Life.
PMID 40868432 Published: 2025-07-25 Ingested: 2026-08-02 12:12 AM Children (Basel, Switzerland)
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 40.1; sample size: 60.0; recency: 90.0; abstract quality: 85.0.

B
Early replacement of re-induction therapy following failed intensive induction treatment enhances the therapeutic efficacy of newly diagnosed AML.
PMID 40481098 Published: 2025-06-06 Ingested: 2026-08-02 12:04 AM Scientific reports
AI -
Standard 75.02
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 82.6; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

B
RNA-seq Molecular Risk Classification Refines Prognostic Stratification in Childhood B-Cell Acute Lymphoblastic Leukemia Treated With the CCCG-ALL-2020 Protocol: A Real-World Cohort Study.
PMID 42496614 Published: 2026-07-24 Ingested: 2026-08-02 12:07 AM Pediatric blood & cancer
AI -
Standard 75.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 40.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.

B
Anti-NMDA receptor encephalitis outcomes in a population-based cohort.
PMID 42458126 Published: 2026-07-15 Ingested: 2026-08-02 12:07 AM Journal of neurology
AI -
Standard 75.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 60.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 384 of 3286
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic